Patents by Inventor Bridget A. Warren

Bridget A. Warren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Colon cancer marker
    Publication number: 20030082603
    Abstract: The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: August 29, 2002
    Publication date: May 1, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Amy W. Lasek, Randi E. Krasnow, Bridget A. Warren, Mariah R. Baughn
  • TNF receptor 2 related protein variant
    Publication number: 20030068619
    Abstract: The invention provides a cDNA which encodes a TNFR2PV. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of cancer and immune disorders, particularly cancer of the prostate, ovary, breast, and brain, or an inflammatory disorder, including rheumatoid arthritis, asthma, and ulcerative colitis. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: July 27, 2001
    Publication date: April 10, 2003
    Inventors: Preeti G. Lal, Bridget A. Warren
  • Colon cancer marker
    Patent number: 6448041
    Abstract: The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: September 10, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Amy K. Wolven, Randi E. Krasnow, Bridget A. Warren, Mariah R. Baughn